Poly(I:C) Induces Human Lung Endothelial Barrier Dysfunction by Disrupting Tight Junction Expression of Claudin-5

• Li-Yun Huang,

  Affiliation Laboratory of Plasma Derivatives, Division of Hematology Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯
• Christine Stuart,

  Affiliation Laboratory of Plasma Derivatives, Division of Hematology Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯
• Kazuyo Takeda,

  Affiliation Microscopy and Imaging Core Facility, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯
• Felice D’Agnillo ,

  * E-mail: Basil.Golding@fda.hhs.gov (BG); Felice.DAgnillo@fda.hhs.gov (FD)

  ¶‡ Joint Senior Authors.

  Affiliation Laboratory of Biochemistry and Vascular Biology, Division of Hematology Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯
• Basil Golding

  * E-mail: Basil.Golding@fda.hhs.gov (BG); Felice.DAgnillo@fda.hhs.gov (FD)

  ¶‡ Joint Senior Authors.

  Affiliation Laboratory of Plasma Derivatives, Division of Hematology Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯